RUBY NASDAQ
Rubius Therapeutics, Inc.
1W: +185.0%
1M: +214.9%
3M: +251.8%
1Y: -76.2%
3Y: -99.3%
5Y: -99.6%
$0.06
Last traded 2023-12-29 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-234M
Net Income
-18.9% YoY
$-155M
Free Cash Flow
-4.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-241.1%
ROA-137.1%
ROIC4542.4%
Valuation
P/E-0.0
P/B0.3
EV/EBITDA0.0
Leverage
Debt/Equity0.07
Current Ratio2.54
Interest Cov.-45.4x
Quality Scores
Piotroski F2/9
Altman Z-75.22
Beneish M0.00